Joan Seoane

Active 1996–2026

76
Papers
21,429
Citations
61
h-index
73
i10-index

Citations

Citations per year for Joan Seoane1993: 1 citations1996: 4 citations1997: 8 citations1998: 7 citations1999: 8 citations2000: 40 citations2001: 53 citations2002: 82 citations2003: 123 citations2004: 100 citations2005: 111 citations2006: 182 citations2007: 167 citations2008: 178 citations2009: 149 citations2010: 171 citations2011: 173 citations2012: 220 citations2013: 149 citations2014: 157 citations2015: 210 citations2016: 227 citations2017: 285 citations2018: 281 citations2019: 725 citations2020: 922 citations2021: 976 citations2022: 803 citations2023: 719 citations2024: 1,061 citations2025: 554 citations2026: 22 citations1994–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,131 citing papers, 26.1% of this breakdownChina: 1,658 citing papers, 13.8% of this breakdownUnited Kingdom: 677 citing papers, 5.6% of this breakdownGermany: 671 citing papers, 5.6% of this breakdownItaly: 625 citing papers, 5.2% of this breakdownSpain: 540 citing papers, 4.5% of this breakdownFrance: 406 citing papers, 3.4% of this breakdownCanada: 379 citing papers, 3.1% of this breakdownJapan: 376 citing papers, 3.1% of this breakdownNetherlands: 343 citing papers, 2.9% of this breakdownSwitzerland: 291 citing papers, 2.4% of this breakdownAustralia: 268 citing papers, 2.2% of this breakdown
0%26.1%Other 22.1%

Fields

  • Biochemistry, Genetics and Molecular Biology49%
  • Medicine42.3%
  • Immunology and Microbiology3.6%
  • Engineering1.6%
  • Neuroscience1.4%
  • Computer Science0.6%
  • Other1.5%

Topics

  • Cancer Genomics and Diagnostics6%
  • Cancer Cells and Metastasis5.1%
  • TGF-β signaling in diseases4%
  • Glioma Diagnosis and Treatment3.4%
  • Lung Cancer Treatments and Mutations2.1%
  • Brain Metastases and Treatment2%
  • Other77.4%

Coauthors

All papers

Open in search
  1. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

    Authors: , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2022 cited by 664

  2. Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research

    Authors: , , , , , , , , , , , , , - Cancer Discovery 2014 cited by 1,760

  3. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 cited by 858

  4. EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2021 cited by 579

  5. Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Rabin, Nancy U. Lin, Eric P. Winer, Anat Stemmer‐Rachamimov, Matthew Meyerson, Levi A. Garraway, Stacey Gabriel, Eric S. Lander, Rameen Beroukhim, Tracy T. Batchelor, José Baselga, David N. Louis, Gad Getz, William C. Hahn - Cancer Discovery 2015 cited by 1,136

  6. Dual inhibition of TGF‐β and PD‐L1: a novel approach to cancer treatment

    Authors: , , , , , , , , - Molecular Oncology 2021 cited by 169

  7. Targeting the Warburg Effect in Cancer: Where Do We Stand?

    Authors: , , - International Journal of Molecular Sciences 2024 cited by 196

  8. Smad transcription factors

    Authors: , , - Genes & Development 2005 cited by 2,441

  9. TGF-β Family Signaling in Tumor Suppression and Cancer Progression

    Authors: , - Cold Spring Harbor Perspectives in Biology 2017 cited by 523

  10. How liquid biopsies can change clinical practice in oncology

    Authors: , , , , , , , , , , - Annals of Oncology 2019 cited by 353

  11. A single-cell tumor immune atlas for precision oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Genome Research 2021 cited by 185

  12. Interrogating open issues in cancer precision medicine with patient-derived xenografts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pier Giuseppe Pelicci, Alejandro Piris‐Giménez, Sergio Roman‐Roman, Oscar M. Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino - Nature reviews. Cancer 2017 cited by 665

  13. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 261

  14. Clinical development of therapies targeting TGFβ: current knowledge and future perspectives

    Authors: , , , - Annals of Oncology 2020 cited by 287

  15. Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Agustín F. Fernández, Mario F. Fraga, Ibán Aldecoa, Leire Pedrosa, Francesc Graus, Noemí Vidal, Fina Martínez‐Soler, Avelina Tortosa, Cristina Carrato, Carmen Balañá, Matthew W. Boudreau, Paul J. Hergenrother, Peter Kötter, Karl-Dieter Entian, Jürgen Hench, Stephan Frank, Sheila Mansouri, Gelareh Zadeh, Pablo D. Dans, Modesto Orozco, George Thomas, Sandra Blanco, Joan Seoane, Thomas Preiß, Pier Paolo Pandolfi, Manel Esteller - Acta Neuropathologica 2019 cited by 194

  16. Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐Marc Plancher, Isabel Cuartas, Joan Seoane, Laurence E. Burgess, Robert T. Abraham, David S. Weinstein, Gabriel M. Simon, Matthew P. Patricelli, Todd M. Kinsella - Nature 2024 cited by 102

  17. Liquid biopsy in gliomas: A RANO review and proposals for clinical applications

    Authors: , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2022 cited by 134

  18. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid

    Authors: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 190

  19. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2012 cited by 404

  20. TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2010 cited by 576

  21. TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma

    Authors: , , , , , , , , , , - Cancer Cell 2009 cited by 524

  22. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Oncology 2014 cited by 378

  23. Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas

    Authors: , , , , , , , , , , , , , , , , , , , - Haematologica 2020 cited by 129

  24. A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel Pérez-López - Radiology 2021 cited by 105